Why Is Intuitive Surgical Stock Surging?
Surgeries are scary for lots of reasons, not least because…
Buy
64
TMO Quote, Financials, Valuation and Earnings
Last price:
$594.99
Seasonality move
:
4.25%
Day range:
$597.00 - $605.05
52-week range:
$493.30 - $627.88
Dividend yield:
0.26%
P/E ratio:
36.16x
P/S ratio:
5.35x
P/B ratio:
4.61x
Volume:
2.2M
Avg. volume:
1.9M
1-year change:
10.9%
Market cap:
$228.6B
Revenue:
$42.9B
EPS (TTM):
$16.53
Analysts' Opinion
-
Consensus RatingThermo Fisher Scientific has received a consensus rating of Buy. The company's average rating is a Buy based on 18 Buy ratings, 7 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $660.39, Thermo Fisher Scientific has an estimated upside of 10.48% from its current price of $597.75.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $585.20 representing 2.1% downside risk from its current price of $597.75.
Fair Value
-
According to the consensus of 25 analysts, Thermo Fisher Scientific has 10.48% upside to fair value with a price target of $660.39 per share.
TMO vs. S&P 500
-
Over the past 5 trading days, Thermo Fisher Scientific has overperformed the S&P 500 by 5.03% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Thermo Fisher Scientific does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Thermo Fisher Scientific has grown year-over-year revenues for 2 quarters straight. In the most recent quarter Thermo Fisher Scientific reported revenues of $11.4B.
Earnings Growth
-
Thermo Fisher Scientific has grown year-over-year earnings for 1 quarter straight. In the most recent quarter Thermo Fisher Scientific reported earnings per share of $4.78.
Enterprise value:
254.5B
EV / Invested capital:
3.14x
Price / LTM sales:
5.35x
EV / EBIT:
30.20x
EV / Revenue:
5.93x
PEG ratio (5yr expected):
5.17x
EV / Free cash flow:
35.02x
Price / Operating cash flow:
31.54x
Enterprise value / EBITDA:
22.06x
Gross Profit (TTM):
$17.8B
Return On Assets:
6.44%
Net Income Margin (TTM):
14.78%
Return On Equity:
13.27%
Return On Invested Capital:
7.7%
Operating Margin:
19.7%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Income Statement | ||||||
| Revenue | $44.9B | $42.9B | $42.9B | $10.9B | $11.4B | |
| Gross Profit | $19B | $17.1B | $17.8B | $4.4B | $4.9B | |
| Operating Income | $8.5B | $7.3B | $7.7B | $1.9B | $2.2B | |
| EBITDA | $11.9B | $11.1B | $11.5B | $3B | $3B | |
| Diluted EPS | $17.63 | $15.45 | $16.53 | $4.20 | $4.78 | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $22B | $20.1B | $25.2B | $24.6B | $22.1B | |
| Total Assets | $69.1B | $95.1B | $97.2B | $98.7B | $97.3B | |
| Current Liabilities | $10.3B | $13.4B | $17B | $14B | $13.3B | |
| Total Liabilities | $34.5B | $54.1B | $53B | $51.9B | $47.7B | |
| Total Equity | $34.5B | $41B | $44.1B | $46.8B | $49.7B | |
| Total Debt | $21.7B | $34.9B | $34.5B | $34.9B | $31.3B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $9.2B | $8.4B | $8.7B | $3.7B | $3.3B | |
| Cash From Investing | -$2.2B | -$5.1B | -$5.8B | -$376M | $20M | |
| Cash From Financing | -$2.8B | -$3.6B | -$6.8B | -$1.4B | -$3.7B | |
| Free Cash Flow | $6.9B | $6.9B | $7.3B | $3.3B | $2.8B | |
TMO
Sector
Market Cap
$228.6B
$44.3M
Price % of 52-Week High
95.2%
47.69%
Dividend Yield
0.26%
0%
Shareholder Yield
2.71%
-0.75%
1-Year Price Total Return
10.9%
-31.77%
Beta (5-Year)
0.774
0.757
Dividend yield:
0.26%
Annualized payout:
$1.56
Payout ratio:
9.2%
Growth streak:
7 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Buy
Level
$583.11
200-day SMA
Buy
Level
$570.28
Bollinger Bands (100)
Buy
Level
526.69 - 598.89
Chaikin Money Flow
Buy
Level
469.7M
20-day SMA
Buy
Level
$562.40
Relative Strength Index (RSI14)
Buy
Level
67.85
ADX Line
Buy
Level
41.59
Williams %R
Sell
Level
-19.0765
50-day SMA
Buy
Level
$538.89
MACD (12, 26)
Buy
Level
15.33
25-day Aroon Oscillator
Buy
Level
80
On Balance Volume
Neutral
Level
303.9M
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (3.8641)
Buy
CA Score
(Annual)
Level (0.0531)
Buy
Beneish M-Score
(Annual)
Level (-2.557)
Buy
Momentum Score
Level (5)
Buy
Ohlson Score
Level (-1.9148)
Buy
Piotroski F Score
(Annual)
Level (7)
Sell
Quality Ratio Score
Level (3)
Buy
Fundamental Score
Level (10)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Thermo Fisher Scientific sells scientific instruments and laboratory equipment, diagnostics consumables, and life science reagents. The firm operates through four segments as of mid-2024 (revenue figures include some cross-segment revenue): analytical technologies (17% of sales); specialty diagnostic products (11%); life science solutions (22%); and lab products and services, which includes CRO services (54%).
Stock Forecast FAQ
In the current month, TMO has received 18 Buy ratings 7 Hold ratings, and 0 Sell ratings. The TMO average analyst price target in the past 3 months is $660.39.
-
Where Will Thermo Fisher Scientific Stock Be In 1 Year?
According to analysts, the consensus estimate is that Thermo Fisher Scientific share price will rise to $660.39 per share over the next 12 months.
-
What Do Analysts Say About Thermo Fisher Scientific?
Analysts are divided on their view about Thermo Fisher Scientific share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Thermo Fisher Scientific is a Sell and believe this share price will drop from its current level to $585.20.
-
What Is Thermo Fisher Scientific's Price Target?
The price target for Thermo Fisher Scientific over the next 1-year time period is forecast to be $660.39 according to 25 Wall Street analysts, 18 of them rate the stock a Buy, 0 rate the stock a Sell, and 7 analysts rate the stock a Hold.
-
Is TMO A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Thermo Fisher Scientific is a Buy. 18 of 25 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of TMO?
You can purchase shares of Thermo Fisher Scientific via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Thermo Fisher Scientific shares.
-
What Is The Thermo Fisher Scientific Share Price Today?
Thermo Fisher Scientific was last trading at $594.99 per share. This represents the most recent stock quote for Thermo Fisher Scientific. Yesterday, Thermo Fisher Scientific closed at $597.75 per share.
-
How To Buy Thermo Fisher Scientific Stock Online?
In order to purchase Thermo Fisher Scientific stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Did Stanley Druckenmiller Buy ARS Pharmaceuticals?
Billionaire Stanley Druckenmiller has been making large changes to his…
Is CVS Health Stock Undervalued?
CVS Health (NYSE:CVS) share price declined by over 23% over…
Stock Ideas
Buy
61
Is AAPL Stock a Buy?
Market Cap: $3.5T
P/E Ratio: 39x
Sell
46
Is MSFT Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Sell
38
Is NVDA Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 101x
Alerts
Buy
54
DECK alert for Feb 3
Deckers Outdoor [DECK] is down 3.28% over the past day.
Sell
49
EXOD alert for Feb 3
Exodus Movement [EXOD] is up 22.29% over the past day.
Buy
73
DOGZ alert for Feb 3
Dogness (International) [DOGZ] is down 5.55% over the past day.
